F. Sica

First urinary tract infections in children: the role of the risk factors proposed by the Italian recommendations

G. Marra, L. Monasta, M. Pennesi, 2018, Acta paediatrica.

Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

A. Edefonti, F. Scolari, P. Ravani, 2015, Journal of the American Society of Nephrology : JASN.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

A. Edefonti, F. Scolari, N. Dallera, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

A. Edefonti, F. Scolari, P. Ravani, 2013, Kidney international.

Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow‐up

G. Marra, V. Fanos, M. Pennesi, 2012, Acta paediatrica.

Updated Italian recommendations for the diagnosis, treatment and follow‐up of the first febrile urinary tract infection in young children

G. Marra, S. Guarino, W. Morello, 2019, Acta paediatrica.

Posterior reversible encephalopathy syndrome (PRES) in a 6-year-old child with nephrotic syndrome

G. Grilli, L. Stoppino, A. Campanozzi, 2020, Radiology case reports.